Shoko Kiritoshi1, Takeshi Soma2. Show Affiliations » 1. Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan. 2. Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan soma@ophthal.med.osaka-u.ac.jp.
Abstract
Entities: Disease
Mesh： See more » Anti-Bacterial Agents/therapeutic useCefmenoxime/therapeutic useCeftriaxone/therapeutic useCorneal Perforation/microbiologyCorneal Perforation/therapyCorneal TransplantationDrug Therapy, CombinationErythromycin/therapeutic useGonorrhea/complicationsGonorrhea/drug therapyHumansKeratoconjunctivitis/microbiologyKeratoconjunctivitis/therapyMaleYoung Adult
Substances： See more » Anti-Bacterial AgentsErythromycinCeftriaxoneCefmenoxime
Year: 2020 PMID： 33139425 PMCID： PMC7647476 DOI： 10.1503/cmaj.200506
Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262